iBio (IBIO) EBT Margin (QoQ) (2011 - 2025)
iBio (IBIO) EBT Margin (QoQ) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,981.90 Bn | 66,981.62 Bn | - |
| 2 | Nanobiotix | 1,913.50 Bn | 1,913.44 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 472.03 Bn | 467.24 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.09 Bn | 114.84 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.01 Bn | 61.26 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.99 Bn | 50.80 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn |
| 10 | iBio | 167.44 Mn | 167.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -317,400.00 |
| Sep 30, 2021 | -4.23 Mn |
| Jun 30, 2021 | -105,370.00 |
| Mar 31, 2021 | 15,149.00 |
| Dec 31, 2020 | 68,437.00 |
| Sep 30, 2020 | -152,140.00 |
| Jun 30, 2020 | 455,467.00 |
| Mar 31, 2020 | -367,147.00 |
| Dec 31, 2019 | 294,045.00 |
| Sep 30, 2019 | -357,202.00 |
| Jun 30, 2019 | 23,372.00 |
| Mar 31, 2019 | -11,519.00 |
| Dec 31, 2018 | 910,478.00 |
| Sep 30, 2018 | -493,177.00 |
| Jun 30, 2018 | 22,656.00 |
| Mar 31, 2018 | -253,557.00 |
| Dec 31, 2017 | 59,476.00 |
| Sep 30, 2017 | -19,746.00 |
| Jun 30, 2017 | 896,860.00 |
| Mar 31, 2017 | -685,488.00 |